Literature DB >> 33639910

Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study.

Giulia Cesaroni1, Gian Francesco Mureddu2, Nera Agabiti3, Flavia Mayer4, Massimo Stafoggia3, Francesco Forastiere3, Roberto Latini5, Serge Masson5, Marina Davoli3, Alessandro Boccanelli6.   

Abstract

BACKGROUND: Although sex differences in cardiovascular diseases are recognised, including differences in incidence, clinical presentation, response to treatments, and outcomes, most of the practice guidelines are not sex-specific. Heart failure (HF) is a major public health challenge, with high health care expenditures, high prevalence, and poor clinical outcomes. The objective was to analyse the sex-specific association of socio-demographics, life-style factors and health characteristics with the prevalence of HF and diastolic left ventricular dysfunction (DLVD) in a cross-sectional population-based study.
METHODS: A random sample of 2001 65-84 year-olds underwent physical examination, laboratory measurements, including N-terminal pro-B-type natriuretic peptide (NT-proBNP), electrocardiography, and echocardiography. We selected the subjects with no missing values in covariates and echocardiographic parameters and performed a complete case analysis. Sex-specific multivariable logistic regression models were used to identify the factors associated with the prevalence of the diseases, multinomial logistic regression was used to investigate the factors associated to asymptomatic and symptomatic LVD, and spline curves to display the relationship between the conditions and both age and NT-proBNP.
RESULTS: In 857 men included, there were 66 cases of HF and 408 cases of DLVD (77% not reporting symptoms). In 819 women, there were 51 cases of HF and 382 of DLVD (79% not reporting symptoms). In men, the factors associated with prevalence of HF were age, ischemic heart disease (IHD), and suffering from three or more comorbid conditions. In women, the factors associated with HF were age, lifestyles (smoking and alcohol), BMI, hypertension, and atrial fibrillation. Age and diabetes were associated to asymptomatic DLVD in both genders. NT-proBNP levels were more strongly associated with HF in men than in women.
CONCLUSIONS: There were sex differences in the factors associated with HF. The results suggest that prevention policies should consider the sex-specific impact on cardiac function of modifiable cardiovascular risk factors.

Entities:  

Keywords:  Diastolic left ventricular dysfunction; Elderly; Heart failure; NT-proBNP; Risk factors; Sex differences

Year:  2021        PMID: 33639910      PMCID: PMC7912519          DOI: 10.1186/s12889-021-10442-3

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  30 in total

Review 1.  The roles of gender, the menopause and hormone replacement on cardiovascular function.

Authors:  C S Hayward; R P Kelly; P Collins
Journal:  Cardiovasc Res       Date:  2000-04       Impact factor: 10.787

Review 2.  Smoothing in occupational cohort studies: an illustration based on penalised splines.

Authors:  E A Eisen; I Agalliu; S W Thurston; B A Coull; H Checkoway
Journal:  Occup Environ Med       Date:  2004-10       Impact factor: 4.402

3.  Inverse probability weighting.

Authors:  Mohammad Ali Mansournia; Douglas G Altman
Journal:  BMJ       Date:  2016-01-15

Review 4.  Sex differences in cardiovascular ageing.

Authors:  Allison A Merz; Susan Cheng
Journal:  Heart       Date:  2016-02-25       Impact factor: 5.994

5.  Heart failure.

Authors:  Henry Krum; William T Abraham
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

6.  High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals.

Authors:  S Masson; R Latini; G F Mureddu; N Agabiti; M Miceli; G Cesaroni; F Forastiere; U-H Wienhues-Thelen; D Block; C Zaugg; T Vago; A Boccanelli
Journal:  J Intern Med       Date:  2012-12-28       Impact factor: 8.989

Review 7.  An Update on Gender Disparities in Coronary Heart Disease Care.

Authors:  Tina Shah; Nicolas Palaskas; Ameera Ahmed
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

8.  Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.

Authors:  Ruby C Lo; Rodney P Bensley; Suzanne E Dahlberg; Robina Matyal; Allen D Hamdan; Mark Wyers; Elliot L Chaikof; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2013-09-29       Impact factor: 4.268

9.  Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy.

Authors:  Gian Francesco Mureddu; Nera Agabiti; Vittoria Rizzello; Francesco Forastiere; Roberto Latini; Giulia Cesaroni; Serge Masson; Giuseppe Cacciatore; Furio Colivicchi; Massimo Uguccioni; Carlo Alberto Perucci; Alessandro Boccanelli
Journal:  Eur J Heart Fail       Date:  2012-05-04       Impact factor: 15.534

10.  Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.

Authors:  Maarten J G Leening; Bart S Ferket; Ewout W Steyerberg; Maryam Kavousi; Jaap W Deckers; Daan Nieboer; Jan Heeringa; Marileen L P Portegies; Albert Hofman; M Arfan Ikram; M G Myriam Hunink; Oscar H Franco; Bruno H Stricker; Jacqueline C M Witteman; Jolien W Roos-Hesselink
Journal:  BMJ       Date:  2014-11-17
View more
  2 in total

Review 1.  Phenotypic and Functional Heterogeneity of Monocyte Subsets in Chronic Heart Failure Patients.

Authors:  Aušra Mongirdienė; Julius Liobikas
Journal:  Biology (Basel)       Date:  2022-01-26

Review 2.  Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate.

Authors:  Beatrice Arosio; Graziamaria Corbi; Sergio Davinelli; Vienna Giordano; Daniela Liccardo; Antonio Rapacciuolo; Alessandro Cannavo
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.